Introduction
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in elderly individuals in the industrialized world [1] . There are two late forms of AMD: the exudative or wet form defined by choroidal neovascularization and the slow developing atrophic form known as geographic atrophy (GA). There is no efficient therapy for GA at the moment. It is characterized by choroidal thinning [2] and a slowly expanding lesion of the photoreceptor cell layer as well as retinal pigment epithelium (RPE) degeneration and dysfunction [3] . GA is a complex multifactorial event influenced by aging [4] , environmental factors, such as smoking history [5] , oxidative stress [6, 7] , and genetic predisposition, particularly haplotypes containing polymorphisms of complement factor H [8] and ARMS2/ HTRA1 [9] . Moreover, low-grade inflammation [10, 11] and accumulation of mononuclear phagocytes in the subretinal space are clearly associated with GA [12] [13] [14] . Adaptive immunity probably also plays a role in AMD pathophysiology [15] . Indeed, 30 years ago, Penfold et al. [16, 17] detected the presence of lymphocytes in the eyes of GA and exudative AMD patients, and they proposed that they may play a role in RPE atrophy and breakdown of Bruch's membrane. Moreover, CD8 + cells have been observed in the choroid of frozen sections of eyes of patients with advanced AMD with or without drusen or fibrovascular scar [18] . Interestingly, Gregerson et al. [19] showed that cytotoxic CD8 + lymphocytes could kill murine RPE cells in vitro by induction of apoptosis in an antigen-dependent manner. Faber et al. [20] demonstrated that the presence of CD56 + CD28
memory T cells in the blood of AMD patients is associated with a 3.5-fold increased risk of developing AMD. The risk of AMD is increased up to 13.3 times in individuals with enhanced levels of memory T cells in the blood and exhibiting at least one complement factor H H402 risk allele. Interleukin-17 (IL-17) is a cytokine that contributes to the pathogenesis of inflammatory and autoimmune diseases [21, 22] , but its role is not restricted to these pathologies [23] . A major source of IL-17 is a lineage of T cells known as CD4 + T helper 17 cells (Th17 cells) which differ from the Th1 and Th2 subsets [24] . IL-17 is secreted by other cell types of the innate and adaptive immune systems, notably macrophages [25, 26] . An increase of IL-17 immunopositivity has been reported in GA eyes compared to control subjects, but IL-17-producing cells could not be identified [27] . Furthermore, genetic variants of IL-17 have been shown to be associated with AMD [28] , while the reported association of hypomethylation of the IL-17 receptor [27] was not reproducible in another study [29] .
In this short report, we show that IL-17 + cells are not found in unaffected donor eyes, but accumulate in the choroid of GA donors near areas of RPE atrophy. They mainly colocalize with CD3 staining, which identifies T lymphocytes, and IBA-1 staining which identifies cells of the monocyte/macrophage family. IL-17, released from infiltrating immune cells, could play an important role in the pathogenesis of GA. 
Materials and Methods

Donor Eyes
Donor eyes with or without a known history of AMD, with GA lesions visible on postmortem fundus photographs confirmed by histological evaluation, and control eyes were obtained from the Minnesota Lions Eye bank [7 control maculae from 7 patients (5 men and 2 women), mean age 84 ± 2.6 years; 13 GA donor maculae from 11 patients (4 men and 7 women), mean age 83.7 ± 2.4 years]. Fundus photographs were taken with a macroscope and an adapted camera by the Minnesota Lions Eye bank. Donor eyes without a known history of eye diseases and no signs of RPE or retinal lesions were considered as being control eyes. Informed consent was obtained for all donor eyes from the Minnesota Lions Eye bank, and experiments conformed to the principles set out in the WMA Declaration of Helsinki.
Histology and Immunohistochemistry
The posterior segment was fixed for 4 h in 4% paraformaldehyde. Then, 8-μm horizontal sections of paraffin-embedded human tissues crossing the optic nerve and perifovea were cut with a microtome (Microm Microtech France). The sections were deparaffinized by incubation in SafeSolv, and rehydration was performed in serial baths of alcohol and water. Some sections of each sample were stained with toluidin blue for histology. Antigen retrieval was performed in boiling EDTA buffer for 15 min. Following inhibition of endogenous peroxidases for 20 min in 0.3% H 2 O 2 (Sigma H1009; 1: 100 in PBS), sections were blocked with 1% purified horse or goat serum and then exposed overnight to rat anti-human CD3e (MCA1477; Serotec), goat anti-human IL-17 (AF-317-NA; R&D Systems), or rabbit anti-IBA-1 (Wako). Alexa fluorescent-conjugated secondary antibody (1: 400; Life Technologies) was used to reveal primary antibodies. Sections were counterstained with 4,6-diamino-2-phenylindole (DAPI). They were imaged with a DM5500 microscope (Leica) or a confocal microscope (LSM 710; Zeiss). Alternatively, anti-IL-17 primary antibodies were incubated with peroxidase labeled horse anti-goat IgG (PI-9500; Vector Laboratories) and revealed with peroxidase substrate kit (SK-4600; Vector Laboratories). IL-17 + cells were counted in the choroid and retina of central control sections as well as in central sections containing GA lesions and divided by the length of the section for the control retina and the length of the GA lesion for AMD eyes (cells/mm). The quantifications were performed on substrate IL-17-stained sections. Ad- 
Statistical Analysis
Graph Pad Prism 6 (GraphPad Software) was used for data analysis and graphic representation. We analyzed 7 control maculae from 7 patients and 13 GA donor maculae from 11 patients. All values are reported as means ± SD. For statistical comparisons, we used the nonparametric Mann-Whitney test. p values <0.05 were considered statistically significant. 
Results and Discussion
Healthy donor eyes revealed a visible fovea on postmortem fundoscopy and a regular histology of the parafovea, recognizable by multilayered ganglion cell nuclei ( fig. 1 a, b) .
GA lesions were visible on postmortem fundus photographs ( fig. 1 c) and confirmed histologically by the missing RPE and thinned photoreceptor cell layer in the lesion of the parafovea (multilayered ganglion cell layer) in the absence of vessels penetrating Bruch's membrane (as observed in neovascular AMD) or a fibroglial scar ( fig. 1 d) .
In GA sections containing the atrophic lesions (fundus photograph and histological section in figure 1 , compared to normal donor sections), we identified IL-17 + cells by immunohistochemistry. Numerous IL-17 + cells were identified in all 13 GA sections, but never in control donor sections ( fig. 2 a) . IL-17 + cells were mainly located within the choroid in proximity to the RPE lesion ( fig. 2 be) and very rarely found in the adjacent retina ( fig. 2 c, g ). Quantification of IL-17 + cells per millimeter of section show a significant increase of IL-17 + cells in GA sections compared to control donor sections ( fig. 2 f) and that they are mainly located in the choroid ( fig. 2 h) .
IL-17 can be secreted by different cell types, but notably by T lymphocytes and macrophages [25] . Indeed, the round nucleus and small cytoplasm of numerous IL-17 + cells ( fig. 2 e) suggested that T lymphocytes participate in IL-17 production in GA. Confocal microscopy of double immunolabeling of IL-17 and CD3 (specifically expressed by T cells [30] ) confirmed that an important portion part of IL-17-producing cells ( fig. 3 a) are CD3 + T lymphocytes ( fig. 3 b and merge in c) . Furthermore, double labeling using the anti-IL17 antibody ( fig. 3 d, g ) and an anti-IBA-1 antibody (monocyte/macrophage marker; fig. 3 fig. 3 d-f) . Nevertheless, future studies are necessary to identify the remaining IL-17-expressing cell types and to elucidate the exact proportions of all different IL-17-expressing cell populations in GA eyes.
In conclusion, our results indicate that IL-17 + cells are invariably present in GA lesions but not observed in agematched control sections confirming earlier studies of increased IL-17 staining in GA [31, 32] . Our study identifies T lymphocytes as an important source of IL-17 in GA. We also showed that IBA-1 + monocytes/macrophages participate in the IL-17 production in the choroid of GA patients. This local IL-17 production could contribute to the increased IL-17 serum concentration found in AMD patients compared to age-matched controls [33] . Moreover, our observations suggest that T cells and monocytes/ macrophages could be responsible for the significant elevation of IL-17 mRNA in maculae of eyes of AMD patients compared to control eyes [34] . It is yet unclear if and how IL-17 contributes to the pathological processes of GA. IL-17 has been shown to directly deteriorate RPE in vitro [32, 35] . Moreover, IL-17 production has been associated with retinal and RPE lesions in a Nrf2-/-mice model of AMD [36] in vivo, and IL-17 could contribute to RPE degeneration in GA.
